Strategic Hires and Promotions, Industry-Leading Platform, and Exclusive Partnerships Support the Future of Pharmaceutical Marketing NEW YORK, March 8, 2022 — DeepIntent, the leading ...
DeepIntent’s Patient Modeled Audiences Solution Uses Industry’s Most Comprehensive Real-World Clinical Datasets to Precisely Reach Patient Populations, Including Those Facing Rare Diseases and Low ...
NEW YORK, Dec. 13, 2021 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, ...
Effective immediately, DeepIntent will have exclusive rights as the only DSP healthcare advertisers can use to reach LG Ads Solutions’ 20+ million households nationwide ...
NEW YORK, Oct. 27, 2021 — DeepIntent, the leading independent healthcare marketing technology company built purposefully to influence patient health and business outcomes, today ...
NEW YORK, Oct. 11, 2021 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, ...
The release marks the industry’s first and only healthcare-specific data marketplace with ready-to-activate and custom audience segments NEW YORK, Sept. 27, 2021 — DeepIntent, ...
With patented technology, the DeepIntent® Demand Side Platform is the first and only proven Demand Side Platform to drive up to 35%* higher script ...
Industry’s First Demand-Side Platform Integrated With Real-World Clinical Data to Increase Script Lift, Improving Business Outcomes for Healthcare Marketers Beta leading pharmaceutical brand experienced ...